Saw-See Hong

612 citations
17 papers · 480 indexed · h-index 11
Topics
Virus-based gene therapy research (11 papers)CAR-T cell therapy research (5 papers)Viral Infections and Immunology Research (4 papers)

In The Last Decade

Saw-See Hong

17 papers receiving 476 citations

Peers

Saw-See Hong
Comparison fields: 5 of 74
  • Molecular Biology 249
  • Cancer Research 116
  • Pulmonary and Respiratory Medicine 110
  • Genetics 104
  • Oncology 85
Replace Wichai Pornthanakasem with:
Wichai Pornthanakasem Thailand
Julia Benckert Germany
Elisabeth Schultheiss Switzerland
Adam D. Swick United States
Florian Ebner Austria
Virendra Joshi United States
Shantan Reddy United States
Pankita H. Pandya United States
Sanami Takada Japan
Saw-See Hong relative to Wichai Pornthanakasem Thailand Wichai Pornthanakasem's profile →
Citations per field
00.5×3.3×
Wichai Pornthanakasem · 1×
Citations per year

Countries citing papers authored by Saw-See Hong

Since Specialization
Citations

This map shows the geographic impact of Saw-See Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saw-See Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saw-See Hong more than expected).

Fields of papers citing papers by Saw-See Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saw-See Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saw-See Hong. The network helps show where Saw-See Hong may publish in the future.

Co-authorship network of co-authors of Saw-See Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Saw-See Hong. A scholar is included among the top collaborators of Saw-See Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saw-See Hong. Saw-See Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 150
2 11
3 32
4 6
5 32
6 84
7 8
8 31
9 4
10 28
11 5
12 8
13 17
14 20
15 14
16 10
17 20

About Saw-See Hong

Saw-See Hong is a scholar working on Virology, Genetics and Infectious Diseases, having authored 17 papers that have together received 480 indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (5 papers) and Viral Infections and Immunology Research (4 papers). The work is most often cited by research in Cancer Research (116 citations), Genetics (104 citations) and Molecular Biology (249 citations). Saw-See Hong has collaborated with scholars based in France, Sweden and United States. Frequent co-authors include Pierre Boulanger, Gaëlle Gonzalez, Francesco Pantano, Françoise Descôtes, Edith Bonnelye, Charles‐Henri Lecellier, Nathalie Allioli, Richard Bachelier, Philippe Clézardin and Kai Bartkowiak. Their work appears in journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026